analyst
TN
NASDAQ · TNGX
Tango Therapeutics, Inc.
Healthcare · Biotechnology
$23.37
Up+$0.55 (+2.35%)
Updated Sep 11, 2026, 5:43 PM
SID Score
5.5/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.01B
- P/E ratio
- -6.93
- Dividend yield
- 0.00%
- 52-week range
- $6.25 – $34.39
- Volume
- 3.44M
- Avg. volume
- 3.27M
Price performance
TNGX price history
1M range · 20 trading sessions · Daily adjusted prices
TNGX closed at $23.37 after 20 trading sessions, down 8.89% for the selected period.
- Last close
- $23.37
- Period change
- -8.89%
- Period low
- $22.32
- Period high
- $25.65
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 10, 2026 | $23.16 | $24.30 | $23.16 | $23.37 | 3.44M |
| Sep 9, 2026 | $22.99 | $25.52 | $22.63 | $24.00 | 4.66M |
| Sep 8, 2026 | $22.50 | $23.08 | $22.26 | $22.70 | 2.42M |
| Sep 4, 2026 | $22.48 | $22.94 | $22.29 | $22.52 | 1.46M |
| Sep 3, 2026 | $22.50 | $22.785 | $22.13 | $22.76 | 1.34M |
| Sep 2, 2026 | $22.62 | $23.122 | $21.635 | $22.32 | 1.92M |
| Sep 1, 2026 | $22.60 | $23.06 | $22.07 | $22.35 | 1.54M |
| Aug 31, 2026 | $23.28 | $23.50 | $22.61 | $22.84 | 1.85M |
| Aug 28, 2026 | $24.93 | $25.085 | $23.275 | $23.34 | 2M |
| Aug 27, 2026 | $25.39 | $26.85 | $25.24 | $25.28 | 2.04M |
| Aug 26, 2026 | $24.65 | $27.00 | $24.26 | $25.47 | 3.17M |
| Aug 25, 2026 | $25.04 | $25.61 | $24.35 | $24.77 | 2.28M |
| Aug 24, 2026 | $23.60 | $24.68 | $22.91 | $24.51 | 2.09M |
| Aug 21, 2026 | $23.95 | $24.36 | $23.48 | $23.88 | 2.49M |
| Aug 20, 2026 | $25.51 | $25.67 | $23.145 | $23.51 | 2.06M |
| Aug 19, 2026 | $26.19 | $26.34 | $25.01 | $25.20 | 1.82M |
| Aug 18, 2026 | $25.00 | $25.95 | $24.97 | $25.44 | 2.28M |
| Aug 17, 2026 | $25.64 | $25.9287 | $25.115 | $25.29 | 2.23M |
| Aug 14, 2026 | $25.21 | $25.70 | $24.7532 | $25.60 | 1.44M |
| Aug 13, 2026 | $25.85 | $25.95 | $25.38 | $25.65 | 2.17M |
Latest TNGX news
The latest Smart Investors Daily articles mentioning TNGX.
Stock researchCompany · Financials
Loading stock research…